The Valley Desk

NCT01325220 · Interventional trial

Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome

Overall registry status Completed

Phase 3

Conditions Fragile X Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov